^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CA102N

i
Associations
Trials
Company:
Holy Stone Healthcare
Drug class:
COX2 inhibitor, CD44-targeted small molecule-drug conjugate
Associations
Trials